These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23303945)

  • 1. A common optimization principle for motor execution in healthy subjects and parkinsonian patients.
    Baraduc P; Thobois S; Gan J; Broussolle E; Desmurget M
    J Neurosci; 2013 Jan; 33(2):665-77. PubMed ID: 23303945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
    Timmermann L; Braun M; Groiss S; Wojtecki L; Ostrowski S; Krause H; Pollok B; Südmeyer M; Ploner M; Gross J; Maarouf M; Voges J; Sturm V; Schnitzler A
    Mov Disord; 2008 Jan; 23(2):218-27. PubMed ID: 18044706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-band oscillations in the supplementary motor cortex are modulated by levodopa and associated with functional activity in the basal ganglia.
    Chung JW; Burciu RG; Ofori E; Coombes SA; Christou EA; Okun MS; Hess CW; Vaillancourt DE
    Neuroimage Clin; 2018; 19():559-571. PubMed ID: 29984164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of deep brain stimulation and medication on strength, bradykinesia, and electromyographic patterns of the ankle joint in Parkinson's disease.
    Vaillancourt DE; Prodoehl J; Sturman MM; Bakay RA; Metman LV; Corcos DM
    Mov Disord; 2006 Jan; 21(1):50-8. PubMed ID: 16124011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Beta Bursts in the Subthalamic Nucleus Predicts Motor Performance.
    Torrecillos F; Tinkhauser G; Fischer P; Green AL; Aziz TZ; Foltynie T; Limousin P; Zrinzo L; Ashkan K; Brown P; Tan H
    J Neurosci; 2018 Oct; 38(41):8905-8917. PubMed ID: 30181135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral subthalamic stimulation effects on oral force control in Parkinson's disease.
    Pinto S; Gentil M; Fraix V; Benabid AL; Pollak P
    J Neurol; 2003 Feb; 250(2):179-87. PubMed ID: 12574948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.
    Katayama Y; Kasai M; Oshima H; Fukaya C; Yamamoto T; Ogawa K; Mizutani T
    J Neurosurg; 2001 Aug; 95(2):213-21. PubMed ID: 11780890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different cerebral cortical areas influence the effect of subthalamic nucleus stimulation on parkinsonian motor deficits and freezing of gait.
    Lyoo CH; Aalto S; Rinne JO; Lee KO; Oh SH; Chang JW; Lee MS
    Mov Disord; 2007 Nov; 22(15):2176-82. PubMed ID: 17712844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of deep brain stimulation in the subthalamic nucleus or globus pallidus internus on step initiation in Parkinson disease: laboratory investigation.
    Rocchi L; Carlson-Kuhta P; Chiari L; Burchiel KJ; Hogarth P; Horak FB
    J Neurosurg; 2012 Dec; 117(6):1141-9. PubMed ID: 23039143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Movement chunking during sequence learning is a dopamine-dependant process: a study conducted in Parkinson's disease.
    Tremblay PL; Bedard MA; Langlois D; Blanchet PJ; Lemay M; Parent M
    Exp Brain Res; 2010 Sep; 205(3):375-85. PubMed ID: 20680249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of subthalamic nucleus deep brain stimulation on axial motor control and protective arm responses in Parkinson's disease.
    Visser JE; Allum JH; Carpenter MG; Esselink RA; Limousin-Dowsey P; Honegger F; Borm GF; Bloem BR
    Neuroscience; 2008 Dec; 157(4):798-812. PubMed ID: 18952153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why don't we move faster? Parkinson's disease, movement vigor, and implicit motivation.
    Mazzoni P; Hristova A; Krakauer JW
    J Neurosci; 2007 Jul; 27(27):7105-16. PubMed ID: 17611263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of deep brain stimulation and medication on bradykinesia and muscle activation in Parkinson's disease.
    Vaillancourt DE; Prodoehl J; Verhagen Metman L; Bakay RA; Corcos DM
    Brain; 2004 Mar; 127(Pt 3):491-504. PubMed ID: 14662520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
    Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Reyns N; Blond S; Guieu JD; Destée A; Defebvre L
    Brain; 2004 Feb; 127(Pt 2):408-19. PubMed ID: 14691060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Parkinson's disease STN stimulation enhances responsiveness of movement initiation speed to high reward value.
    Kojovic M; Higgins A; Jahanshahi M
    Neuropsychologia; 2016 Aug; 89():273-280. PubMed ID: 27371365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral subthalamic nucleus lesion reverses L-dopa-induced motor fluctuations and facilitates dyskinetic movements in hemiparkinsonian rats.
    Marin C; Jiménez A; Tolosa E; Bonastre M; Bové J
    Synapse; 2004 Feb; 51(2):140-50. PubMed ID: 14618681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease.
    Moro E; Scerrati M; Romito LM; Roselli R; Tonali P; Albanese A
    Neurology; 1999 Jul; 53(1):85-90. PubMed ID: 10408541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
    Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
    Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential modulation of STN-cortical and cortico-muscular coherence by movement and levodopa in Parkinson's disease.
    Hirschmann J; Özkurt TE; Butz M; Homburger M; Elben S; Hartmann CJ; Vesper J; Wojtecki L; Schnitzler A
    Neuroimage; 2013 Mar; 68():203-13. PubMed ID: 23247184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.